Tecnovatica S.A. (WSE:TEC)

Market Cap	5.65M -16.8%
Revenue (ttm)	52.62K +163.1%
Net Income	69.77K
EPS	0.01
Shares Out	10.75M
PE Ratio	81.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,325
Average Volume	39,470
Open	0.4800
Previous Close	0.5060
Day's Range	0.4800 - 0.5280
52-Week Range	0.2280 - 0.7950
Beta	0.11
RSI	55.04
Earnings Date	Apr 2, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC